Inventor
HAKOGI TOSHIKAZU
JP12 patents
⚠️ This page may combine multiple inventors who share the name “HAKOGI TOSHIKAZU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIONOGI & CO
5 patentsUS9012650B2Apr 21, 2015
Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents
SHIONOGI & CO2 citations61
US9707246B2Jul 18, 2017
Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents
SHIONOGI & CO0 citations51
US9133216B2Sep 15, 2015
(3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10
SHIONOGI & CO0 citations51
US8981129B2Mar 17, 2015
2-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4
SHIONOGI & CO0 citations51
US8669362B2Mar 11, 2014
Processes and Intermediates for carbamoylpyridone HIV integrase inhibitors
SHIONOGI & CO1 citations49
JOHNS BRIAN ALVIN
3 patentsUS8580967B2Nov 12, 2013
Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof
JOHNS BRIAN ALVIN8 citations91
US8552187B2Oct 8, 2013
Processes and intermediates for carbamoylpyridone HIV integrase inhibitors
JOHNS BRIAN ALVIN14 citations82
US8217034B2Jul 10, 2012
Chemical compounds
JOHNS BRIAN ALVIN18 citations82
DAISO CO LTD
2 patentsVIIV HEALTHCARE CO
2 patentsUS8940912B2Jan 27, 2015
4-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acid
VIIV HEALTHCARE CO0 citations50
US8765965B2Jul 1, 2014
1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7
VIIV HEALTHCARE CO0 citations47